This page lists the SEC filings reported by Orbimed Advisors.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-05-08 | ORBIMED ADVISORS LLC | Kinnate Biopharma Inc. | 7,559,729 | 16.2% | EDGAR |
| SC 13D/A | 2023-05-05 | ORBIMED ADVISORS LLC | Xtant Medical Holdings, Inc. | 73,114,592 | 67.1% | EDGAR |
| SC 13D/A | 2023-05-03 | ORBIMED ADVISORS LLC | Kinnate Biopharma Inc. | 6,098,797 | 13.1% | EDGAR |
| SC 13D/A | 2023-04-21 | ORBIMED ADVISORS LLC | TELA Bio, Inc. | 2,866,267 | 11.9% | EDGAR |
| SC 13D | 2023-04-12 | ORBIMED ADVISORS LLC | Apollomics Inc. | 662,561 | 10.3% | EDGAR |
| SC 13D/A | 2023-04-07 | ORBIMED ADVISORS LLC | Galecto, Inc. | 2,696,654 | 10.5% | EDGAR |
| SC 13D | 2023-03-31 | ORBIMED ADVISORS LLC | Gracell Biotechnologies Inc. | 7,583,576 | 11.2% | EDGAR |
| SC 13D/A | 2023-03-29 | ORBIMED ADVISORS LLC | Terns Pharmaceuticals, Inc. | 7,619,135 | 13.4% | EDGAR |
| SC 13D/A | 2023-03-24 | ORBIMED ADVISORS LLC | 89bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-03-24 | ORBIMED ADVISORS LLC | CalciMedica, Inc. | 297,380 | 5.4% | EDGAR |
| SC 13D/A | 2023-03-22 | ORBIMED ADVISORS LLC | CalciMedica Inc | 297,380 | 18.9% | EDGAR |
| SC 13D/A | 2023-03-14 | ORBIMED ADVISORS LLC | Theseus Pharmaceuticals, Inc. | 17,233,668 | 39.6% | EDGAR |
| SC 13D/A | 2023-02-28 | ORBIMED ADVISORS LLC | Fusion Pharmaceuticals Inc. | 2,930,670 | 4.7% | EDGAR |
| SC 13D | 2023-02-28 | ORBIMED ADVISORS LLC | Enliven Therapeutics, Inc. | 8,949,339 | 21.8% | EDGAR |
| SC 13D/A | 2023-02-23 | ORBIMED ADVISORS LLC | Kinnate Biopharma Inc. | 4,693,629 | 10.6% | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED ADVISORS LLC | Aeglea BioTherapeutics, Inc. | 1,797,221 | 2.9% | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED ADVISORS LLC | Applied Therapeutics Inc. | 7,300,921 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED ADVISORS LLC | CATALYST BIOSCIENCES, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED ADVISORS LLC | Crinetics Pharmaceuticals, Inc. | 2,710,710 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED ADVISORS LLC | Gracell Biotechnologies Inc. | 1,914,198 | 2.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.